CoChat

Atorvastatin ameliorates depressive behaviors and neuroinflammatory in streptozotocin-induced diabetic mice

Hai-Na, Zhang, Xu-Ben, Yu, Cong-Rong, Tang, Yan-Cheng, Cao, Fan, Yang, Lei-Mei, Xu, Ruo-Lan, Sun, Ye-Zi, Ye-Xuan, Wang, Jing, Liang · 2020 · Psychopharmacology

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Abstract

Depression is a chronic and progressive syndrome and commonly associated with several neuropsychiatric comorbidities, of which depression is the most studied. It has been demonstrated that statins also have anti-inflammatory and immunomodulatory properties, which being explored for potential benefits in depression. However, the role of statins in the treatment of diabetes-related depression has not been well examined. Herein, we investigated the effects of atorvastatin on depressive behaviors and neuroinflammation in streptozotocin-induced diabetic mice. Our data indicated that oral administration of atorvastatin at 10 or 20 mg/kg for 3 weeks markedly ameliorated diabetes-associated depressive behaviors reflected by better performance in sucrose preference test (SPT), tail suspension test (TST), and novelty-suppressed feeding test (NSFT). The study further showed that atrovastatin decreased the expression of nucleus NF-κB p65 expression and ameliorated neuroinflammatory responses in prefrontal cortex as evidenced by less Iba-1-positive cells and lower inflammatory mediators including IL-1β and TNF-α. As expected, atorvastatin-treated diabetic mice exhibited significant improvement of hyperlipidemia rather than hyperglycemia. These results suggest that atorvastatin has the potential to be employed as a therapy for diabetes-related depression.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00213-019-05406-w

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 58 references

Cited by

See all 29

Metadata

Authors
Hai-Na, Z., Xu-Ben, Y., Cong-Rong, T., Yan-Cheng, C., Fan, Y., Lei-Mei, X., Ruo-Lan, S., Ye-Zi, Ye-Xuan, W., & Jing, L.
Affiliations
Wenzhou Medical University (CN)
Venue
Psychopharmacology
Published
2019-11-30
Volume
237
Issue
3
Pages
695-705
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2994246648
Cited by
29
References
59
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 1
FWCI
0.74
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Science Foundation of the Zhejiang Pharmaceutical Association (2018ZYY43, 2017ZYY20)
  • the Science Foundation of Wenzhou (S20100050)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
atorvastatin, diabetes-related depression, neuroinflammation, streptozotocin-induced diabetes, NF-κB p65, prefrontal cortex, microglia, IL-1β, TNF-α, hyperlipidemia, statins, depression-like behavior
MeSH terms
Atorvastatin, Animals, Anti-Inflammatory Agents, Depression, Diabetes Mellitus, Experimental, Dose-Response Relationship, Drug, Hippocampus, Inflammation, Male, Streptozocin, Tumor Necrosis Factor-alpha, Prefrontal Cortex, Inflammation Mediators, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hindlimb Suspension, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Atorvastatin ameliorates depressive behaviors and neuroinflammatory in streptozotocin-induced diabetic mice. https://app.cochat.ai/papers/10.1007/s00213-019-05406-w
The paper
Hai-Na, Z., Xu-Ben, Y., Cong-Rong, T., Yan-Cheng, C., Fan, Y., Lei-Mei, X., Ruo-Lan, S., Ye-Zi, Ye-Xuan, W., & Jing, L. (2020). Atorvastatin ameliorates depressive behaviors and neuroinflammatory in streptozotocin-induced diabetic mice. Psychopharmacology. https://doi.org/10.1007/s00213-019-05406-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.